Introduction {#s1}
============

Blinding eye diseases like macular degeneration, glaucoma, and diabetic retinopathy result in retinal neuron death which leads to vision loss. Unlike mammals, zebrafish have a remarkable ability to regenerate neurons that were lost due to injury or disease ([@bib20]; [@bib31]; [@bib68]). Key to this regenerative response are Müller glia (MG) the major glial cell type in the retina of both fish and mammals. The normal function of MG is to maintain retinal structure and homeostasis ([@bib6]; [@bib33]; [@bib51]). However, in fish, MG respond to retinal injury by dividing and generating multipotent progenitors for neuron regeneration ([@bib4]; [@bib17]; [@bib18]; [@bib45]; [@bib47]; [@bib50]).

Although it is not known why MG from fish and mammals respond differently to retinal injury, it likely results from differences in their environment and intrinsic differences that are reflected in their gene expression programs. Unlike mammals, the zebrafish retina continues to grow throughout life and this growth-permissive environment may impact MG's potential to mount a regenerative response ([@bib23]). Zebrafish MG themselves also appear to contribute to a pro-regenerative environment by releasing growth factors and cytokines after retinal injury ([@bib7]; [@bib28]; [@bib41]; [@bib48]; [@bib66]; [@bib67]; [@bib76]). Dying neurons and immune cells may also contribute to the pro-regenerative MG niche in fish. In addition to niche factors, intrinsic differences in gene expression programs in MG from fish and mammals have been noted ([@bib56]). In fish, Ascl1a and Lin28a are critical factors promoting MG reprogramming and proliferation ([@bib14]; [@bib16]; [@bib21]; [@bib34]; [@bib35]; [@bib46]; [@bib48]). *ascl1a* and *lin28a* RNAs are highly induced in MG following injury to the fish retina, while their homologs remain undetectable in the injured mouse retina ([@bib14]; [@bib26]). However, forced expression of Ascl1, along with HDAC inhibition or Lin28a expression can stimulate a limited proliferative response by MG in the injured mouse retina ([@bib14]; [@bib25]).

Another intrinsic difference between MG from fish and mammals is Notch signaling. In mice, Notch signaling declines as MG differentiate and mature; while in fish, Notch signaling is maintained into adulthood ([@bib3]; [@bib13]; [@bib14]; [@bib19]; [@bib39]; [@bib69]; [@bib66]). The maintenance of Notch signaling in MG of the adult zebrafish retina contributes to MG quiescence and Notch suppression is required for MG proliferation ([@bib11]; [@bib14]; [@bib58]; [@bib69]; [@bib66]). Furthermore, the opposing actions of Fgf8a on MG proliferation in juvenile and adult fish is correlated with corresponding changes in Notch signaling activity ([@bib69]). Thus, Notch signaling is a major control point in the decision to proliferate or remain quiescent and understanding how Notch signaling is regulated in the zebrafish retina will help reveal mechanisms underlying MG's decision to mount a regenerative response.

In addition to Notch signaling, Tgfb signaling has been implicated in regulating injury-dependent MG proliferation in the zebrafish retina ([@bib10]; [@bib30]; [@bib52]; [@bib53]; [@bib57]). However, there are inconsistencies among these reports with some suggesting it is inhibited in proliferating MG ([@bib30]; [@bib52]) and others suggesting it is activated in these cells ([@bib10]; [@bib53]; [@bib57]). Although most of the above studies suggest Tgfb signaling inhibits MG proliferation, one study suggests it is necessary for injury-dependent MG proliferation ([@bib53]). Besides these inconsistencies, the endogenous ligand responsible for stimulating Tgfb signaling and the downstream signaling components responsible for regulating MG proliferation remain unknown.

In zebrafish, Tgfb ligands are encoded by four genes: *tgfb1a*, *tgfb1b*, *tgfb2*, and *tgfb3*. Canonical Tgfb signaling occurs when a Tgfb ligand engages a type II receptor that recruits type I (Alk5) receptor to stimulate phosphorylation of Smad2 and Smad3, which stimulates their nuclear import and allows for regulation of target genes ([@bib55]). Non-canonical Tgfb signaling refers to receptors that engage Erk, Jnk, p38, or protein phosphatase 2A (PP2A)-dependent pathways ([@bib12]; [@bib43]). Identification of the specific Tgfb ligands mediating retina regeneration in fish and unravelling their mechanism of action are critical for understanding how the Tgfb signaling pathway regulates MG proliferation and retina regeneration.

Here we provide evidence indicating Tgfb3 controls MG quiescence via a non-canonical Tgfb signaling pathway. Of all Tgfb ligand encoding genes, we find *tgfb3* expression is uniquely restricted to quiescent MG in the adult zebrafish retina. Following retinal injury, this expression is suppressed at the injury site. Using transgenic fish that allow for conditional expression of Tgfb3, we show that *tgfb3* suppression is necessary for injury-dependent MG proliferation. Interestingly, our studies reveal a specificity in the actions of Tgfb ligands on MG proliferation with Tgfb3, but not Tgfb1b, stimulating MG quiescence. Our studies suggest PP2A and Notch signaling pathways act downstream of Tgfb3. Furthermore, we report that Tgfb3 stimulates pSmad3 expression in the injured retina; however, pSmad3 expression is not sufficient to drive MG quiescence. Finally, we report that the Tgfb3 expression is not detectable in mouse MG, and this may contribute to their poor regenerative potential.

Results {#s2}
=======

pSmad3 signaling is suppressed in injury-responsive MG {#s2-1}
------------------------------------------------------

pSmad3 immunofluorescence was used to detect canonical Tgfb signaling in the uninjured retina of *gfap:GFP* transgenic fish. This analysis revealed that pSmad3 expression was restricted to GFP+ MG ([Figure 1A](#fig1){ref-type="fig"}). Importantly, this expression was suppressed when fish were immersed in water containing the Tgfb receptor 1 (Alk5) kinase inhibitors SB431542 or SB505124 ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}; [@bib65]).

![pSmad3 expression in the uninjured and injured retina.\
(**A**) Retinal section from uninjured *gfap:GFP* fish retina with GFP (green) and pSmad3 (red) immunofluorescence. Arrowheads point to pSmad3 expressing MG. (**B**) pSmad3 immunofluorescence in uninjured and needle poke injured retina. Asterisk marks injury site. (**C**) Quantification of data shown in (**B**). (**D**) Top diagram shows time line for heat shock treatment after injury and when fish were sacrificed. Bottom panels show pSmad3 immunofluorescence in injured and heat shock-treated Wt and *hsp70:ca-Alk5* transgenic fish. Asterisk marks the injury site and arrowheads point to recovery of pSmad3 expression at the injury site in heat shock-treated *hsp70:ca-alk5* transgenic fish. White dot in lower panel marks non-specific autofluorescence in the photoreceptor layer. (**E**) Quantification of data shown in (**D**). (**F**) Top diagram is time line for experiment illustrating injury, heat shock treatment and BrdU labelling prior to sacrifice. Lower panels show BrdU immunofluorescence in Wt and *hsp70:ca-alk5* fish. Asterisk marks the injury site. (**G**) Quantification of data presented in (**F**). Error bars are SD. \*\*p\<0.01, \*\*\*p\<0.001. Scale bar is 50 microns.](elife-55137-fig1){#fig1}

We next investigated if pSmad3 expression was regulated by retinal injury. A needle poke was used to cause a focal injury ([@bib17]). This manipulation stimulated a rapid depletion in pSmad3 expression at the injury site ([Figure 1B--C](#fig1){ref-type="fig"}), which was rescued after heat shock of *hsp70:ca-Alk5* transgenic fish that express a constitutively active Tgfb receptor 1 (ca-Alk5, T204D) under the control of a *hsp70* heat shock promoter ([Figure 1D--E](#fig1){ref-type="fig"}; [@bib70]; [@bib77]). Furthermore, forced expression of ca-Alk5 inhibited injury-dependent MG proliferation ([Figure 1F--G](#fig1){ref-type="fig"}). However, when TUNEL stain was used to identify apoptotic cells, very few TUNEL+ cells were identified ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). Thus, the reduced injury-dependent MG proliferation noted with ca-Alk5 overexpression may reflect increased pSmad signaling and/or reduced cell death. Regardless, these data indicate that Tgfb signaling via pSmad3 expression correlates with MG proliferation in the injured retina.

### *tgfb3* expression correlates with injury-dependent pSmad3 expression {#s2-1-1}

To identify injury-responsive Tgfb ligands that might regulate pSmad3 signaling in the retina, we interrogated RNAseq data sets from MG and MG-derived progenitors that were isolated from uninjured *gfap:GFP* and injured *1016 tuba1a:GFP* transgenic fish retinas, respectively ([@bib17]; [@bib27]). This analysis indicated constitutive and low expression of *tgfb1a*; injury-dependent induction of *tgfb1b* and *tgfb2*; and injury-dependent suppression of *tgfb3* ([Figure 2A](#fig2){ref-type="fig"}). qPCR was used to validate the RNAseq data ([Figure 2B--C](#fig2){ref-type="fig"}; [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). Injury-dependent reduction in *tgfb3* RNA was also evident following NMDA-mediated amacrine and ganglion cell death or genetic ablation of photoreceptors using metronidazole-treated *zop:nsfb-EGFP* transgenic fish that harbor a zebrafish rod opsin promoter driving expression of bacterial nitroreductase that converts metronidazole into a cytotoxic product ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}; [@bib37]; [@bib45]).

![Injury-dependent regulation of *tgfb* gene expression.\
(**A**) RNAseq was used to quantify *tgfb* gene expression in FACS purified GFP+ MG isolated from uninjured and injured (2 dpi) *gfap:GFP* and *1016 tuba1a:GFP* fish retinas, respectively. Fold change in gene expression following retinal injury is indicated above the bars. (**B**) qPCR quantification of *tgfb* gene expression in GFP+ MG FACS purified from uninjured *gfap:GFP* fish retina (normalized to *tgfb1b*). (**C**) qPCR quantification of *tgfb* gene expression following retinal injury normalized to uninjured levels. Total retinal RNA was used for qPCR. Error bars are SD. \*p\<0.05. (**D**) *tgfb3 in situ* hybridization and GS (glutamine synthetase) immunofluorescence in adult fish retina shows *tgfb3* RNA is expressed in MG. Top panel is *tgfb3* in situ hybridization; bottom panel is overlay of *in situ* hybridization and GS immunofluorescence. Arrowheads point to *tgfb3*-expressing MG. Scale bar is 50 microns. \*p\<0.05, \*\*\*p\<0.001.](elife-55137-fig2){#fig2}

We also compared the relative expression of *tgfb* ligand encoding RNAs in the retinal neuron (GFP-) and MG (GFP+) cell populations that were separated by FACS using dissociated cells from uninjured *gfap:GFP* fish retinas. This analysis showed *tgfb3* is highly enriched in MG, whereas *tgfb1b* and *tgfb2* are more equally distributed between these different cell populations ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). *In situ* hybridization assays for *tgfb3* combined with glutamine synthetase (GS) immunofluorescence on retinal sections confirmed *tgfb3* gene expression is restricted to GS+ MG in the uninjured retina ([Figure 2D](#fig2){ref-type="fig"}).

We next used *in situ* hybridization assays to investigate when during development this MG-specific *tgfb3* expression profile emerges. Consistent with a previous report ([@bib8]), we found transient expression of *tgfb3* RNA in the lens at 24 hpf (hours post fertilization) ([Figure 3A](#fig3){ref-type="fig"}). At 96 hpf when MG are differentiating ([@bib3]), we do not detect significant levels of *tgfb3* RNA in the retina, nor do we observe significant *tgfb3* expression at 7 dpf (days post fertilization). By 10 dpf, *tgfb3* RNA is detected in the central region of the retina where more mature MG reside ([Figure 3A](#fig3){ref-type="fig"}). This expression continues to increase with age and the adult expression pattern is established by 3 mpf (months post fertilization) ([Figure 3A](#fig3){ref-type="fig"}). Consistent with our RNAseq and qPCR data indicating very low *tgfb1b* levels in the retina ([Figure 1A--B](#fig1){ref-type="fig"}), we were unable to detect zebrafish *tgfb1b* gene expression by *in situ* hybridization at any of the time points examined ([Figure 3A](#fig3){ref-type="fig"}).

![*tgfb3* expression in developing and adult retina.\
(**A**) *tgfb3 in situ* hybridization identifies *tgfb3* expression in lens at 24 hpf (hours post fertilization) and in MG beginning \~10 dpf (days post fertilization). This latter expression continues to increase throughout the first 3 months of development. Note *tgfb1b* expression remains undetectable by *in situ* hybridization at all the time points examined (14 dpf and 3 mpf). Size marker is 20 microns. In the 10 and 20 dpf panels, black arrowheads point to *tgfb3* expressing MG in the central retina, while white arrowheads point to reduced *tgfb3* expression in the retinal periphery. (**B**) *In situ* hybridization (blue/purple product) and Sox9 immunofluorescence (green fluorescence) identifies *tgfb3* expression in GCL and INL, but not in MG of the mouse retina. Size marker is 25 microns. (**C**) Retinal injury suppresses *tgfb3* expression at the injury site in 3 month old fish. *In situ* hybridization detects *tgfb3* RNA (blue/purple product) and BrdU immunofluorescence (red/orange fluorescence) identifies proliferating cells. Size marker is 40 microns.](elife-55137-fig3){#fig3}

We next examined *Tgfb3* expression in the 1 month old mouse retina. This analysis showed *Tgfb3* expression was confined to cells in the GCL and INL ([Figure 3B](#fig3){ref-type="fig"}). Co-staining retinal sections for *Tgfb3* RNA and Sox9 immunofluorescence (MG marker) showed no overlap, indicating *Tgfb3*+ cells in the INL are not MG ([Figure 3B](#fig3){ref-type="fig"}).

Although the lack of detectable Tgfb3 expression in the developing (1--7 dpf) fish retina suggests Tgfb3 expression is not necessary for MG differentiation, low levels of expression may go undetected by *in situ* hybridization. Therefore, we investigated if knocking down Tgfb3 expression with a translation-blocking morpholino-modified antisense oligonucleotide (MO) would affect MG differentiation. Control or *tgfb3*-MOs were delivered into single cell zebrafish embryos and at 6 dpf, fish were sacrificed and retinal sections assayed for glutamine synthetase (GS) immunofluorescence which serves as a marker of differentiated MG. This analysis revealed normal GS reactivity in the developing retina regardless of Tgfb3 knockdown ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). We confirmed the *tgfb3*-MO's effectiveness by observing reduced GFP in embryos injected with a *tgfb3-EGFP* fusion RNA and the *tgfb3*-MO, but not with control MO ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}).

Because of concerns that MO-mediated Tgfb3 knockdown may not be effective at 6 dpf due to MO dilution during cell division, we generated *tgfb3*^-/-^ fish using a CRISPR/Cas9 strategy ([Figure 3---figure supplement 1C--E](#fig3s1){ref-type="fig"}). In these fish, an insertion mutation changes the *tgfb3* reading frame so a premature stop codon is introduced in exon 1 ([Figure 3---figure supplement 1E](#fig3s1){ref-type="fig"}). We found that *tgfb3*^-/-^ fish die around 2 weeks post fertilization. Therefore, we selected *tgfb3*^+/+^, *tgfb3*^+/-^ and *tgfb3*^-/-^ fish at 12 dpf to assay for retinal GS expression. Normal GS immunofluorescence was observed in both *tgfb3*^+/-^ and *tgfb3*^-/-^ fish retinas suggesting Tgfb3 does not impact MG differentiation ([Figure 3---figure supplement 1F](#fig3s1){ref-type="fig"}). However, we do note that retinas were smaller in *tgfb3*^-/-^ fish.

We next used *in situ* hybridization assays to investigate the spatial pattern of *tgfb3* expression in the injured adult retina. This analysis revealed that *tgfb3* RNA is specifically suppressed at the injury site and that this suppression preceded MG proliferation that begins \~2 dpi ([Figure 3C](#fig3){ref-type="fig"}).

Together, the above results indicate that *tgfb3* expression in the zebrafish retina correlates with MG maturation, pSmad3 expression, and MG quiescence.

Injury-dependent Tgfb3 suppression is required for MG proliferation {#s2-2}
-------------------------------------------------------------------

To investigate if Tgfb3 suppression was required for injury-dependent MG proliferation, we generated *hsp70:tgfb3* transgenic fish that allow conditional expression of Tgfb3 with heat shock. A 1 hr heat shock at 37°C resulted in over a 100-fold induction of *tgfb3* RNA that persisted for over 3 hr and then returned to basal levels around 24 hr post heat shock ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). To examine the effect Tgfb3 had on MG proliferation in the injured retina, *hsp70:tgfb3* transgenic fish received a needle poke injury and then a 1 hr heat shock every 6 hr for 4 days. Three hours before sacrifice at 4 dpi, fish received an IP (intraperitoneal) injection of BrdU to label proliferating cells. This analysis showed that forced expression of Tgfb3 suppressed MG proliferation in the injured retina ([Figure 4A--B](#fig4){ref-type="fig"}), without any significant effect on injury-dependent cell death ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}).

![Tgfb3 suppresses MG proliferation and reprogramming gene expression.\
(**A**) Top illustration is experimental time line. Bottom panels are BrdU immunofluorescence in injured and heat shock-treated Wt and *hsp70:tgfb3* transgenic fish. Asterisk marks injury site. Scale bar is 50 microns. (**B**) Quantification of data in (**A**). (**C**) Top illustration is experimental time line. Fish received a needle poke injury and a 1 hr heat shock and then sacrificed at 6 hpi for RNA analysis by qPCR. Bottom graph is qPCR quantification of select reprogramming gene expression levels in the indicated fish lines at 6 hpi. (**D**) Experimental time line is as in (**C**) and *tgfb3* levels were assayed in the indicated fish lines at 6 hpi. (**E**) Top illustration is experimental time line. Bottom panel is qPCR analysis of *ascl1a* and *tgfb3* gene expression with and without the indicated MO treatment. MO, is morpholino-modified antisense oligonucleotide used to knockdown expression from the indicated gene. Error bars are SD. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001.](elife-55137-fig4){#fig4}

We next investigated if Tgfb3 depletion affected spontaneous or injury-dependent MG proliferation. Because *tgfb3^-/-^* fish do not survive to adults, we knocked down Tgfb3 with a *tgfb3*-targeting MO and determined if there was an effect on MG proliferation. Control or *tgfb3*-MO was delivered intravitreally and cellular uptake facilitated by electroporation as previously described ([@bib61]). Retinas were injured and at 3 dpi fish received an IP injection of EdU 3 hr prior to sacrifice. Quantification of EdU+ and TUNEL+ cells revealed Tgfb3 knockdown had no effect on MG proliferation or cell death at either the injury site or in undamaged regions of the retina ([Figure 4---figure supplement 1B--C](#fig4s1){ref-type="fig"}).

Together, the above data indicate Tgfb3 suppression is necessary for injury-dependent MG proliferation, but this suppression is not sufficient to drive MG proliferation in the uninjured retina.

Tgfb3 regulates MG reprogramming {#s2-3}
--------------------------------

Reprogramming MG for retinal repair requires the regulation of gene expression programs that stimulate MG proliferation and the expansion of a MG-derived progenitor population. Essential components of these programs are genes encoding growth factors, cytokines, and transcription factors that are rapidly induced following a retinal injury ([@bib21]; [@bib38]; [@bib41]; [@bib40]; [@bib46]; [@bib48]; [@bib49]; [@bib60]; [@bib69]; [@bib66]; [@bib67]; [@bib76]). Because *tgfb3* expression is suppressed within a few hours post injury, we suspected it might regulate these gene expression programs. To investigate this, we injured Wt or *hsp70:tgfb3* fish retinas and immediately treated fish with a single 1 hr heat shock before sacrificing fish at 6 hpi and isolating retinal RNA for gene expression analysis using qPCR. Interestingly, we found that many reprogramming genes that are normally induced after retinal injury, like *ascl1a*, *hbegfa*, *lepb*, *crlf1a*, and *socs3a*, were suppressed by Tgfb3 expression, while genes normally repressed soon after injury, like *fgf8a* and *dll4* were unaffected ([Figure 4C](#fig4){ref-type="fig"}). Furthermore, forced Fgf8a expression, which we previously showed suppressed injury-dependent MG proliferation in the adult retina ([@bib69]), had no effect on *tgfb3* expression ([Figure 4D](#fig4){ref-type="fig"}). Thus, Tgfb3 and Fgf8a appear to act independent of each other to regulate MG proliferation.

The observation that *ascl1a* gene expression is suppressed in a Tgfb3-dependent manner was intriguing since it is a critical reprogramming gene that along with Lin28a and Notch inhibition is sufficient to stimulate spontaneous MG proliferation in the uninjured retina ([@bib14]). We previously reported that injury-dependent induction of cytokines, like Crlf1a and Lepb, acting via gp130-coupled receptors, also act upstream of *ascl1a* to drive MG proliferation ([@bib76]). Therefore, we wondered if Tgfb3 was part of this early cytokine response system. For this analysis we took advantage of previously characterized MOs to knockdown cytokine signaling in the injured retina and assayed *ascl1a* and *tgfb3* gene expression ([Figure 4E](#fig4){ref-type="fig"}; [@bib76]). This analysis confirmed that injury-dependent *ascl1a* gene induction is regulated by a cytokine signaling system, and that this signaling system also contributes to injury-dependent *tgfb3* suppression ([Figure 4E](#fig4){ref-type="fig"}). Thus, Tgfb3 and cytokine-related gene products seem to contribute to a feedback loop regulating each other's expression and also regulating MG proliferation.

Together, these data suggest Tgfb3 drives MG quiescence in the injured retina, at least in part, by inhibiting the expression of pro-regenerative gene expression programs.

Tgfb1b overexpression stimulates pSmad3 expression without affecting MG proliferation {#s2-4}
-------------------------------------------------------------------------------------

qPCR and RNAseq analysis of *tgfb* gene expression in the injured retina revealed that although *tgfb1b* and *tgfb2* were induced in the injured retina, their levels remained below the suppressed levels of *tgfb3* ([Figure 2A](#fig2){ref-type="fig"}). Furthermore, injury-dependent regulation of pSmad3 expression followed that of *tgfb3*, but not *tgfb1a*, *tgfb1b*, or *tgfb2* ([Figures 1B](#fig1){ref-type="fig"}, [2A](#fig2){ref-type="fig"} and [3C](#fig3){ref-type="fig"}). These observations suggest that Tgfb3 expression largely accounts for pSmad3 expression in the uninjured and injured retina. Whether other Tgfb ligands could also inhibit MG proliferation via a pSmad3 signaling mechanism remained unknown, but seemed likely if we boosted their levels to at least that of Tgfb3 in the uninjured retina. To investigate this, we generated *hsp70:tgfb1b* transgenic fish.

*hsp70:tgfb1b* fish treated with a 1 hr heat shock exhibited over a 100-fold induction of *tgfb1b* RNA that returned to basal levels \~ 24 hr later ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). Overexpression of Tgfb1b had no significant effect on endogenous *tgfb2b* expression, but did decrease *tgfb3* expression by \~50% at 6 hr post heat shock ([Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). Interestingly, when comparing the consequence of Tgfb1b and Tgfb3 overexpression on MG proliferation and pSmad3 expression, only Tgfb3 suppressed injury-dependent MG proliferation ([Figure 5A--B](#fig5){ref-type="fig"}), but both Tgfb1b and Tgfb3 reestablished pSmad3 expression at the injury site ([Figure 5C](#fig5){ref-type="fig"}).

![Tgfb1b and Tgfb3 stimulate pSmad3 expression, but only Tgfb3 inhibits injury-dependent MG proliferation.\
(**A**) Top illustration is experimental time line. Bottom panels show BrdU immunofluorescence on retinal sections from uninjured and injured, heat shock-treated Wt, *hsp70:tgfb1b*, and *hsp70:tgfb3* transgenic fish. (**B**) Quantification of data in (**A**). (**C**) pSmad3 immunofluorescence on retinal sections from uninjured and injured, heat shock-treated Wt, *hsp70:tgfb1b*, and *hsp70:tgfb3* transgenic fish. Arrowheads point to the INL at the injury site. Asterisk marks the injury site. White dot in two right-hand panels marks non-specific autofluorescence in the photoreceptor layer. Scale bar is 50 microns. Error bars are SD. \*\*p\<0.01.](elife-55137-fig5){#fig5}

Although Tgfb1b overexpression did not regulate MG proliferation, *tgfb1b* RNA is induced in the injured retina ([Figure 2A and C](#fig2){ref-type="fig"}), and we wondered if this induction had any consequence on regeneration. Therefore, we knocked down Tgfb1b expression with a previously validated splice-blocking *tgfb1b*-targeting MO ([Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}; [@bib36]). MOs were delivered to retinas at the time of injury and cellular uptake facilitated by electroporation. Four days later, fish received an IP injection of EdU and 3 hr later some fish were sacrificed to assay MG proliferation ([Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}), while others were allowed to survive until 14 dpi to lineage trace EdU+ MG ([Figure 5---figure supplement 1E](#fig5s1){ref-type="fig"}). These analyses revealed that Tgfb1b knockdown had no significant effect on injury-dependent MG proliferation or the fate of MG-derived progenitors ([Figure 5---figure supplement 1D--E](#fig5s1){ref-type="fig"}).

Together, the above data indicate specificity in the action of Tgfb ligands on MG proliferation and suggest that pSmad3 expression does not drive MG quiescence in the injured retina.

Alk5 and PP2A inhibition rescue MG proliferation in injured retinas with Tgfb3 overexpression {#s2-5}
---------------------------------------------------------------------------------------------

The above data suggested that Tgfb3-dependent activation of Alk5 may engage a non-canonical Tgfb signaling pathway to regulate MG proliferation. To investigate this, we first determined the effect Alk5 suppression had on MG proliferation in heat shock-treated *hsp70:tgfb3* fish immersed in either DMSO or the Alk5 inhibitor, SB431542 ([Figure 6A](#fig6){ref-type="fig"}). As expected, Alk5 inhibition rescued MG proliferation in injured retinas from heat shock-treated *hsp70:tgfb3* fish ([Figure 6B--C](#fig6){ref-type="fig"}).

![Alk5 and PP2A inhibition rescues Tgfb3-mediated inhibition of MG proliferation in the injured retina.\
(**A**) Experimental time line. (**B**) Edu click chemistry identifies proliferating MG in retinal sections from injured Wt and *hsp70:tgfb3* transgenic fish treated with heat shock, +/- okadaic acid (OKA), PD169316 (PD), or SB431542 (SB) treatment. Scale bar is 50 microns. (**C**) Quantification of the effects of OKA, PD, and SB on Tgfb3-mediated suppression of MG proliferation that is shown in (**B**). Edu values are normalized to MG proliferation in Tgfb3 overexpressing transgenic fish. Error bars are SD. \*\*p\<0.01.](elife-55137-fig6){#fig6}

We next investigated if Tgfb3-dependent activation of Alk5 engaged a non-canonical Tgfb signaling pathway, like ERK, PI3K, p38, and PP2A ([@bib12]; [@bib43]; [@bib73]; [@bib75]). Previous studies indicated that ERK and PI3K signaling are necessary for injury-dependent MG proliferation and therefore, are not candidates for conveying the quiescence-promoting effects of Tgfb3 ([@bib66]; [@bib67]). Therefore, we focused our analysis on PP2A and p38.

PP2A functions as a trimer with a dimeric core consisting of a catalytic (zebrafish genes *ppp2ca*, *ppp2cb*) and structural subunit (zebrafish genes *ppp2r1a*, *ppp2r1b*) and one of 7 regulatory subunits (zebrafish genes *ppp2r2aa, ppp2r2ab, ppp2r2ba, ppp2r2bb, ppp2r2ca, ppp2r2cb, ppp2r2d*) that confers subcellular targeting, substrate specificity, and regulation of holoenzyme phosphatase activity. Importantly, the PP2A Bα subunit (zebrafish Ppp2r2aa and Ppp2r2ab) can associate with and be phosphorylated by Alk5, and this association/phosphorylation is necessary to transduce the anti-proliferative effects of Tgfb receptor signaling ([@bib22]; [@bib43]; [@bib72]). Interrogation of RNAseq data sets indicates that genes encoding PP2A components and p38 isoforms (*mapk14a*, *mapk14b*) are expressed in quiescent and injury-responsive MG ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}).

We next investigated if PP2A or p38 signaling participated in Tgfb3-dependent regulation of MG proliferation in the injured retina. For this analysis, Wt and *hsp70:tgfb3* transgenic fish retinas were injured and fish were either left untreated or received a 1 hr heat shock every 6 hr for 4 days along with daily intravitreal injections of either DMSO, the PP2A inhibitor okadaic acid (10 μM, OKA), or the p38 MAPK inhibitor PD169316 (3 μM, PD) ([@bib5]; [@bib71]). Fish received an IP injection of EdU 3 hr prior to sacrifice to label proliferating cells. Quantification of EdU+ cells revealed that inhibition of PP2A, but not p38 MAPK, rescued MG proliferation in retinas with Tgfb3 overexpression ([Figure 6C](#fig6){ref-type="fig"}). Neither forced expression of Tgfb3 or intravitreal injection of OKA affected injury-dependent apoptosis ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}).

Together, the above data suggests Alk5 and PP2A act downstream of Tgfb3 to regulate MG quiescence.

Notch inhibition rescues MG proliferation in Tgfb3-expressing injured retinas {#s2-6}
-----------------------------------------------------------------------------

Previous studies revealed that Notch signaling inhibition is required for injury-dependent MG proliferation ([@bib11]; [@bib14]; [@bib69]; [@bib66]). Therefore, we wondered if Tgfb3 signaling acted through Notch signaling to inhibit MG proliferation. To investigate this, we bred *hsp70:tgfb3* fish with *tp1:mCherry* Notch reporter fish that harbor 12 RBP-Jk binding sites upstream of a minimal promoter that drives nuclear localized mCherry expression ([@bib42]). Normally, Notch signaling is suppressed in injury-responsive MG spanning the injury site ([Figure 7A](#fig7){ref-type="fig"}, *tp1:mCherry* panel) ([@bib14]; [@bib69]). However, forced Tgfb3 expression in *hsp70:tgfb3;tp1:mCherry* double transgenic fish prevented this injury-dependent suppression in Notch signaling ([Figure 7A--B](#fig7){ref-type="fig"}) and this correlated with reduced MG proliferation ([Figure 4A--B](#fig4){ref-type="fig"}). Furthermore, we found that Tgfb3-dependent inhibition of MG proliferation can be rescued by pharmacological suppression of Notch signaling using the γ-secretase inhibitor RO4929097 ([Figure 7C--D](#fig7){ref-type="fig"}). Consistent with these data, Tgfb3 overexpression in the uninjured retina increased expression of the Notch reporter gene *hey1*, and the ligand encoding gene, *dll4*. However, *dll4* induction did not reach statistical significance ([Figure 7E](#fig7){ref-type="fig"}) and further studies are needed to determine if Tgfb3 regulates Notch signaling via *dll4* expression. Nonetheless, the above studies suggest Tgfb3 acts, at least in part, via the Notch signaling pathway to regulate MG quiescence.

![Tgfb3 acts upstream of Notch signaling to inhibit MG proliferation.\
(**A**) Top illustration is experimental time line. Bottom panels show mCherry immunofluorescence on retinal sections from either injured *tp1:mCherry* or *hsp70:tgfb3;tp1:mCherry* transgenic fish. Asterisk and box region shows the injury site. Note forced Tgfb3 expression stimulate mCherry expression. (**B**) Quantification of data mCherry+ cells shown in (**A**). (**C**) Top is experimental time line. Bottom panels show BrdU immunofluorescence on retinal sections from injured and heat shock-treated Wt and *hsp70:tgfb3* fish treated +/- RO4929097. (**D**) Quantification of data in (**C**). (**E**) qPCR analysis of *dll4* and *hey1* RNA expression using total retinal RNA from Wt and *hsp70:tgfb3* fish that were given a 1 hr heat shock (HS) treatment before sacrifice. Values are normalized to Wt control. Error bars are SD. \*p\<0.05, \*\*\*p\<0.001. Scale bar is 50 microns.](elife-55137-fig7){#fig7}

Discussion {#s3}
==========

Here we report that Tgfb3 signaling regulates MG quiescence in the zebrafish retina. Although both Tgfb1b and Tgfb3 can induce pSmad3 expression, only Tgfb3 stimulates MG quiescence, suggesting the involvement of a non-canonical Tgfb signaling pathway. We found that PP2A or Notch inhibition partially rescued MG proliferation in injured retinas overexpressing Tgfb3 and that Tgfb3 acts, at least in part, by stimulating Notch signaling. We also found that Tgfb3-driven MG quiescence is associated with suppression of regeneration-associated genes. Finally, our study reveals that *tgfb3* is highly expressed by pro-regenerative MG of the zebrafish retina, but remains undetectable in non-regenerative MG of the mouse retina.

Tgfb ligands are expressed as latent pre-pro-polypeptides that must be released from latency for their action ([@bib54]). Prior to secretion, the immature polypeptide is cleaved between the prodomain and mature peptide domain, but they remain associated. The prodomain is required for proper folding, dimerization, and binding to integrin in the extracellular matrix. In order for Tgfb ligands to signal through their receptors they must be released from the prodomain, which is accomplished via integrin interaction. Among the four different Tgfb ligand encoding genes expressed in the uninjured retina, our data suggests that Tgfb3 predominates. Tgfb3 expression is restricted to quiescent MG and its suppression is required for MG proliferation. Our data suggest that Tgfb3 is constitutively released from integrin in the extracellular matrix and that *tgfb3* gene expression is a major control point in regulating Tgfb signaling in MG.

The mechanism by which *tgfb3* expression is suppressed in the injured retina remains unknown, but diffusible factors emanating from either dying neurons and/or immune cells that accumulate at the injury site are good candidates. The observation that both the ligand (Tgfb3) and the response (pSmad3) are restricted to MG suggests that Tgfb3 acts in an autocrine or paracrine fashion; however, we cannot rule out the involvement of an intervening neuronal or immune cell. An autocrine/paracrine type of regulation may be a common theme in the injured zebrafish retina since most of the reported secreted factors regulating MG proliferation emanate from MG themselves ([@bib41]; [@bib69]; [@bib66]; [@bib76]).

In the adult mammalian retina, Tgfb signaling is low and Tgfb expression does not correlate with MG quiescence or proliferation ([@bib1]; [@bib29]; [@bib32]; [@bib63]). However, similar to what we observed in adult fish retina, Tgfb signaling has been associated with reduced MG proliferation in young chicks and postnatal rats ([@bib9]; [@bib62]), and with reduced stem cell proliferation in certain regions of the mouse brain ([@bib15]). The high basal level of *tgfb3* in mature MG from zebrafish, but not mice, is intriguing and one cannot help but speculate that it may contribute to their stemness. Interestingly, Notch signaling has been reported to contribute to neural stem cell stemness in the adult zebrafish brain ([@bib59]), and in the retina, our data indicates Tgfb3 stimulates Notch signaling. Thus, Tgfb3 expression in the zebrafish retina provides a mechanism for maintaining Notch signaling into adulthood, which is absent in mammals.

Our conclusion that Tgfb3-pSmad3 signaling is active in quiescent MG and suppressed following retinal injury differs from previous reports ([@bib10]; [@bib30]; [@bib53]; [@bib57]). However, even among these previous studies, inconsistencies emerge, reinforcing the importance of carefully controlled experiments. [@bib30] assayed the expression of putative Tgfb responsive genes, like *tgif1* and *tgfbi* to concluded Tgfb signaling was transiently induced prior to injury-dependent MG proliferation and then repressed when MG proliferate. In contrast, [@bib57] used pSmad3 immunofluorescence to conclude Tgfb signaling was increased in proliferating MG. Further disparities emerge when examining the effect of the Tgfb signaling inhibitor SB431542 on MG proliferation in the INL where [@bib57] reported no effect, and [@bib53] reported inhibition. Remarkably, even in work coming from the same group, inconsistencies emerge. For example, when assaying *tgfb* gene expression, one report suggests increased injury-dependent *tgfb1a* expression, while another indicated reduced *tgfb1a* expression ([@bib10]; [@bib57]); and another group reported Tgfb signaling is inhibited in an Oct4-dependent fashion in injury-responsive MG, while a later report indicates enhanced Tgfb signaling in these reprogrammed MG ([@bib52]; [@bib53]). The reason for these disparities is not known, but reinforces the idea that manipulating and assaying Tgfb signaling in the zebrafish retina is not trivial. We also note that many of these studies relied solely on SB431542 to inhibit Tgfb signaling; however, this drug is a more potent inhibitor of CK1 and RIPK2 ([@bib65]), which further clouds the interpretation of results.

In the work reported here, we not only suppressed Tgfb signaling with SB431542 and the more specific Alk5 inhibitor, SB505124 ([@bib65]), but also stimulated Tgfb signaling with conditional expression of Tgfb1b, Tgfb3, and ca-Alk5 using transgenic fish. All these manipulations resulted in the expected change in pSmad3 immunofluorescence in MG, supporting our contention that pSmad3 immunofluorescence reflects Tgfb signaling. Importantly, we found that Tgfb signaling is active in quiescent MG and rapidly suppressed in injury-responsive MG, and that this suppression correlates with *tgfb3* gene expression that was visualized by *in situ* hybridization and quantified by RNAseq and qPCR. Furthermore, unlike previous studies, we determined the relative proportion of RNAs encoding different *tgfb* isoforms, revealing *tgfb3* is expressed at least 80-fold higher than the other isoforms in quiescent MG, and the only isoform to be repressed after retinal injury. These data suggest that Tgfb3 is largely responsible Tgfb signaling in quiescent MG. Remarkably, [@bib10] reported a \~ 2 fold increase in *tgfb3* expression at 1--14 dpi, which is inconsistent with their previous study ([@bib57]), and hard to reconcile with our data.

Using transgenic fish, we found that forced expression of Tgfb3, but not Tgfb1b, suppressed injury-dependent MG proliferation. This result contrasts with [@bib53] who reported intravitreal injection of recombinant human Tgfb1 enhanced MG reprogramming and proliferation in the injured. Zebrafish Tgfb1b shares 42% amino acid identity with human TGFb1, and it is not clear if the human ligand will engage zebrafish Tgfb receptors and stimulate pSmad3 expression in the zebrafish retina. Although transgenic approaches used to conditionally express zebrafish ligands are generally preferable to intravitreal injection of human factors, these transgenic approaches do have their limitations since heat shock causes cell stress, and the *hsp70* promoter is induced in all retinal cell types. Our studies suggest that heat shock-induced cell stress had no effect on MG proliferation in wild type and *hsp70:tgfb1b* fish; however, we were unable to achieve conditional, cell-type specific expression of Tgfb3, so it remains possible that some of its actions are indirectly related to its expression in retinal neurons.

One of the more remarkable observations we made during this study is that bothTgfb3 and Tgfb1b can stimulate pSmad3 expression, but only Tgfb3 can drive MG quiescence. This suggested that Tgfb3 must be mediating if effects on MG proliferation via a non-canonical Tgfb signaling pathway. Although the mechanism coupling Tgfb3-dependent activation of Alk5 to MG quiescence remains unknown, our data indicates that it impacts Notch signaling as indicated by increased *tp1:mcherry* transgene and endogenous *hey1* expression.

Experiments designed to rescue MG proliferation in Tgfb3 overexpressing retinas revealed a role for Alk5 and PP2A in regulating MG quiescence. Although it is not surprising that inhibition of Tgfb3's Alk5 receptor would relieve its effects on MG proliferation, the observation that this phenotype is recapitulated by PP2A inhibition was unexpected. Interestingly, PP2A can be recruited to Alk5 to stimulate G1 arrest ([@bib22]; [@bib43]; [@bib72]), and PP2A is a major regulator of cell cycle check points and signaling pathways that impinge on the cell cycle, like Wnt, MAPK, PI3K, and mTor ([@bib72]). Importantly, these PP2A-regulated signaling pathways have been previously shown to contribute to injury-dependent MG proliferation ([@bib48]; [@bib66]; [@bib67]; [@bib74]). However, additional studies are needed to determine the mechanism of action of PP2A in regulating MG quiescence and in particular, whether it directly interacts with Alk5.

Materials and methods {#s4}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                               Designation                                        Source or reference                                                      Identifiers                                                      Additional\
  (species) or resource                                                                                                                                                                                                                    information
  ------------------------------------------- -------------------------------------------------- ------------------------------------------------------------------------ ---------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------
  Strain, strain background (*Danio rerio)*   *1016 tuba1a:GFP*                                  [@bib17]                                                                                                                                  

  Strain, strain background (*Danio rerio*)   *gfap:GFP*                                         [@bib27]                                                                                                                                  

  Strain, strain background (*Danio rerio)*   *tp1:mCherry*                                      [@bib42]                                                                                                                                  

  Strain, strain background (*Danio rerio)*   *zop:nsfb-EGFP*                                    [@bib37]                                                                                                                                  

  Strain, strain background (*Danio rerio)*   *hsp70:ca-Alk5*                                    [@bib77]                                                                                                                                  

  Strain, strain background (*Danio rerio)*   *hsp70:tgfb1b*                                     This paper; [Figure 5](#fig5){ref-type="fig"}                                                                                             *tgfb1b* expressed under the *hsp70* promoter; generated using Tol2-mediated transgenesis -Goldman lab

  Strain, strain background (*Danio rerio)*   *hsp70:tgfb3*                                      This paper; [Figure 4](#fig4){ref-type="fig"}                                                                                             *tgfb3* expressed under the *hsp70* promoter; generated using Tol2-mediated transgenesis -- Goldman lab

  Sequence-based reagent                      *Tgfb3-*MO                                         Gene Tools, LLC                                                                                                                           Lissamine-tagged, *tgfb3*-targeting Morpholino 5'TGCATGGTTAA TATCTGCACACTAT

  Sequence-based reagent                      *Tgfb1b-*MO                                        Gene Tools, LLC                                                                                                                           Lissamine-tagged, *tgfb1b*-targeting Morpholino 5'AAGGATAGTG CCACTCACTCATTGT

  Sequence-based reagent                      T7 universal gRNA primer                           Sigma-Aldrich                                                                                                                             T7 universal gRNA primer 5'-AAAAGCACCGACTCGGTG CCACTTTTTCAAGTTGATAAC GGACTAGCCTTATTTTAACTT GCTATTTCTAGCTCTAAAAC-3'

  Sequence-based reagent                      *tgfb3* gRNA one primer                            Sigma-Aldrich                                                                                                                             *tgfb3* gRNA one primer: 5'-TAATACGACTCACTAT AGGGCACCTGACTAGGG CCCAGTTTTAGAGCTAGAA

  Sequence-based reagent                      *tgfb3* gRNA two primer                            Sigma-Aldrich                                                                                                                             *tgfb3* gRNA two primer: 5'-TAATACGACTCACTAT AGGCCCTCTACAACAGC ACCAGTTTTAGAGCTAGAA

  Sequence-based reagent                      PCR primers                                                                                                                                                                                  See Materials and Methods - Primers and Morpholinos section below

  Recombinant DNA reagent                     *pCS2+ tgfb3-EGFP*                                 This paper; [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}                                                                    Vector for generating RNA that has tgfb3 MO target sequence appended to the 5' end of the EGFP mRNA coding sequence - Goldman lab.

  Recombinant DNA reagent                     *pCS2-nCas9n-nanos3'UTR*                           Addgene, Plasmid \#62542                                                 Plasmid \#62542                                                  

  Antibody                                    anti-pSmad3, rabbit monoclonal                     Abcam                                                                    Cat. \# ab52903\                                                 1/200 dilution
                                                                                                                                                                          RRID:[AB_882596](https://scicrunch.org/resolver/AB_882596)       

  Antibody                                    Zpr-1, mouse monoclonal                            Zebrafish International Resource Center                                  Cat. \# zpr-1\                                                   1/500 dilution
                                                                                                                                                                          RRID:[AB_10013803](https://scicrunch.org/resolver/AB_10013803)   

  Antibody                                    Zn-5, mouse monoclonal                             Zebrafish International Resource Center                                  Cat. \# zn-5\                                                    1/1000 dilution
                                                                                                                                                                          RRID:[AB_10013770](https://scicrunch.org/resolver/AB_10013770)   

  Antibody                                    anti-HuC/D, rabbit polyclonal                      Abcam                                                                    Cat. \# ab210554\                                                1/500 dilution
                                                                                                                                                                          RRID:[AB_210554](https://scicrunch.org/resolver/AB_210554)       

  Antibody                                    anti-PKC~β1~, mouse monoclonal                     Santa Cruz Biotechnology                                                 Cat. \# SC-8049\                                                 1/200 dilution
                                                                                                                                                                          RRID:[AB_628143](https://scicrunch.org/resolver/AB_628143)       

  Antibody                                    anti-glutamine synthetase (GS), mouse monoclonal   Sigma-Aldrich                                                            Cat. \# MAB302\                                                  1/500 dilution
                                                                                                                                                                          RRID:[AB_2110656](https://scicrunch.org/resolver/AB_2110656)     

  Antibody                                    anti-SOX9, rabbit polyclonal                       Millipore Sigma                                                          Cat. \# AB5535\                                                  1/500 dilution
                                                                                                                                                                          RRID:[AB_2239761](https://scicrunch.org/resolver/AB_2239761)     

  Antibody                                    anti-BrdU, rat monoclonal                          Thermo Fisher                                                            Cat. \#\                                                         1/500 dilution
                                                                                                                                                                          MA 182088\                                                       
                                                                                                                                                                          RRID:[AB_927214](https://scicrunch.org/resolver/AB_927214)       

  Antibody                                    anti-BrdU, mouse monoclonal                        Thermo Fisher                                                            Cat. \# B35128\                                                  Clone MoBu-1 for co-staining with EdU Click-it Chemistry, 1/500 dilution
                                                                                                                                                                          RRID:[AB_2536432](https://scicrunch.org/resolver/AB_2536432)     

  Chemical compound, drug                     SB431542                                           Fisher Scientific                                                        Cat \# 16--141                                                   Tgfb signaling inhibitor

  Chemical compound, drug                     SB505124                                           Fisher Scientific                                                        Cat \# 32-631-0                                                  Tgfb signaling inhibitor

  Chemical compound, drug                     RO4929097                                          Cayman Chemical                                                          Cat \# 19996                                                     Notch signaling inhibitor

  Chemical compound, drug                     okadaic acid                                       Cell Signaling Technology                                                Cat \# 5934                                                      PP2A inhibitor

  Chemical compound, drug                     PD169316                                           Cayman Chemical                                                          Cat \# 10006727                                                  P38 MAPK inhibitor

  Commercial assay or kit                     mMESSAGE mMACHINESP6 Transcription Kit             Invitrogen                                                               Cat \# AM1340                                                    mRNA synthesis

  Commercial assay or kit                     Megascript T7 Transcription Kit                    Invitrogen                                                               Cat \# AM1334                                                    mRNA synthesis

  Commercial assay or kit                     In situ cell death, fluorescein                    Sigma Aldrich                                                            Cat \# 11684795910                                               TUNEL assay
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Animals, injury models, and cell proliferation assays {#s4-1}
-----------------------------------------------------

Animal studies were approved by the University of Michigan's Institutional Animal Care and Use Committee. Zebrafish were kept at 26--28°C with a 10/14 hr light/dark cycle. Adult male and female fish from 6 to 12 months of age were used in these studies. *1016 tuba1a:GFP*, *gfap:GFP*, *tp1:mCherry*, *zop:nsfb-EGFP*, and *hsp70:ca-Alk5* fish were previously described ([@bib17]; [@bib27]; [@bib37]; [@bib42]; [@bib77]). We generated *hsp70:tgfb1b* and *hsp70:tgfb3* transgenic fish using standard recombinant DNA techniques using Tol2 vector backbone. Expression constructs were injected into single cell zebrafish embryos as previously described ([@bib17]). Fish were anesthetized in tricaine and retinas were injured with a needle poke injury (2--4 injuries/retina for analysis of proliferation and protein expression on retinal sections and 8--10 injuries/retina when harvesting total RNA for qPCR), NMDA, or genetically as previously described ([@bib17]; [@bib37]; [@bib45]). To investigate cell proliferation, fish received an IP injection of BrdU or EdU (10 μl of 10 mg/ml stock) as indicated in the text and detected by immunofluorescence or Click-It chemistry as previously described ([@bib69]). Wild-type FVB/N mice were obtained from our breeding colony.

RNA isolation, PCR, and RNAseq {#s4-2}
------------------------------

Total RNA was isolated using Trizol (Invitrogen). cDNA synthesis and PCR reactions were performed as previously described ([@bib16]; [@bib46]). Real-time qPCR reactions were carried out in triplicate with ABsolute SYBR Green Fluorescein Master Mix (Thermo Scientific) on an iCycler real-time PCR detection system (BioRad). The ΔΔCt method was used to determine relative expression of mRNAs in control and injured retinas and normalized to either *gapdh* or *gapdh~s~* mRNA levels. Individual comparisons were done using unpaired 2-tailed Student t-test. ANOVA with Fisher\'s PLSD post hoc analysis was used for multiple parameter comparison. Error bars are standard deviation (SD).

For RNAseq, retinas from *1016 tuba1a:GFP* and *gfap:GFP* fish were dissociated and GFP+ MG were purified using FACS using the University of Michigan's Cell Sorting Core as previously described ([@bib44]; [@bib46]). RNA from GFP+ cells was used to generate libraries and DNA was sequenced on an Illumina HiSeq2000 instrument. Sequencing reads were analyzed by the University of Michigan's Bioinformatics Core. The number of reads for each expressed gene was determined and differentially expressed genes were restricted to those exhibiting at least a 2-fold difference in expression with threshold abundance greater than 5 Fragments Per Kilobase of transcript per Million mapped reads to eliminate very low abundant transcripts whose estimates of fold-change are unreliable. GEO accession for RNAseq data is GSE145330.

Generation of *tgfb3* mutant fish {#s4-3}
---------------------------------

Gene editing was performed as previously described ([@bib24]; [@bib64]). Briefly, CRISPRscan (<https://www.crisprscan.org/>) was used to identify gRNA target sequences in exon 1 of the *tgfb3* gene. gRNAs were transcribed using PCR products as a templates and the MEGAscript T7 transcription kit (Thermo Fisher Scientific \#AM1334). *Cas9-nanos* mRNA was transcribed using NotI-digested *Cas9-nanos pCS2* expression vector and the mMESSAGE mMACHINE SP6 kit (Invitrogen, \#AM1340). *Cas9-nanos* mRNA and two gRNAs targeting *tgfb3* exon1 were co-injected into one cell stage zebrafish embryos. Primers for making *tgfb3* mutant fish: T7 universal gRNA primer: 5'-AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC-3'; gRNA one primer: 5'-TAATACGACTCACTATAGGGCACCTGACTAGGGCCCAGTTTTAGAGCTAGAA; gRNA two primer: 5'-TAATACGACTCACTATAGGCCCTCTACAACAGCACCAGTTTTAGAGCTAGAA.

Primers and morpholinos (MO) used in this study {#s4-4}
-----------------------------------------------

The following PCR primers are 5' to 3'. *tgfb3*: forward GATTGGAGGGACGGATGA, reverse GTGACAGGGGCAGTGAAC; *tgfb2*: forward CAGCATGAGAGCCACAGAC, reverse CTCCACAGATACGGACAGG; *tgfb1a*: forward GTACAAACACCACAACCCTGG, reverse GGCTTACTTATCAATCCCGAC; *tgfb1b*: forward ACTGGCTCTTGCTCCTAT, reverse AACTGTTCCACCTTATGC; *ascl1a*: forward TTGAGCGTTCGTAAA, reverse GCTGAAGGACTGGATT; *fgf8a*: forward CAGTGTGGATACAAACGCAGG, reverse TAGCAAAACGCAAAGAGGTGA; *lepb*: forward CATTGCTCGAACCACCATCAGC, reverse TCTTTATGCACCGGGGTCTCG; *crlf1a*: forward GGGATTCTGGGATCTAGGAAAGC, reverse TCCTTGAAGAACCTGGTTGCG; *socs3a*: forward CACTAACTTCTCTAAAGCAGGG, reverse GGTCTTGAAGTGGTAAAACG; *il-11b*: forward GCTAACAGTGTCGCCTGACTCC, reverse CTGTAGTTCAGTGAGGGCAGGG; *dll4*: forward GGAAATTTGACGTGCTCCAT, reverse GAGAAAGGTGAGCCAAGCTG; *hbegf*: forward CGATGGATGGCGAGGATGTAGA, reverse GCATTAGGGCAGGACGAAGTTG; *hey1*: forward GTTTGCATTTTCACGCCCCT, reverse CGCCCTCTAGTGCTCACATT; *tgfb3* gRNA mutation forward GGCAAAGGACTGCTGTTTGT, reverse GAGATCCCTGGATCATGTTGA; *tgfb1b* MO mis-splicing forward GCACACCATAGAAGATCCAACA, reverse AGGCATCTGCAACCAGTCTT.

Lissamine-tagged, *tgfb3*-targeting MO: 5'TGCATGGTTAATATCTGCACACTAT; Lissamine-tagged, *tgfb1b*-targeting MO: 5'AAGGATAGTGCCACTCACTCATTGT; Gene Tools standard control MO: 5' CCTCTTACCTCAGTTACAATTTATA.

Morpholino (MO) functional assays {#s4-5}
---------------------------------

For testing *tgfb3*-targeting MO, we generated *pCS2+tgfb3 EGFP* construct that contained *tgfb3* cDNA MO target site upstream and in-frame with the EGFP initiator AUG. Primers for generating *tgfb3* MO targeting sequence are: forward primer (BamHI): 5'-GCAGGATCCGGAGCCGCTTCATTCATCTG-3' and reverse primer (Nco1): 5'-TCACCATGGTGGACAGAGACAAGCTCATG-3'. The *pCS2+tgfb3 EGFP* plasmid was linearized with Not1 restriction enzyme and capped sense *tgfb3-EGFP* RNA was synthesized using SP6 RNA polymerase using Invitrogen's mMESSAGE mMACHINE SP6 Transcription Kit (Invitrogen, \#AM1340) according to manufactures directions. Following purification, the capped *tgfb3-EGFP* RNA was dissolved in nuclease free water containing 0.2% phenol red and injected with experimental or control MO into single cell zebrafish embryos. Each embryo received approximately 50 pg of RNA and 250 pg of control or experimental MO. For testing splice blocking *tgfb1b*-targeting MO, we injected either control MO (2.4 ng) or *tgfb1b*-targeting MO (0.3 ng and 2.4 ng) into single cell zebrafish embryos. RNA was extracted from embryos at 24--48 hr post injection and assayed for *tgfb1b* mRNA by PCR.

Heat shock and pharmacological inhibitors {#s4-6}
-----------------------------------------

For heat shock, fish were immersed in a water bath at 37°C for 1 hr before returning to system water at 28°C. For extended periods of heat shock, this was repeated every 6 hr. For inhibition of Tgfb signaling we used two different Tgfb receptor 1 (Alk 5) inhibitors, SB431542 and SB505124 (Fisher Scientific) and to inhibit Notch signaling we used RO4929097 (Cayman). PP2A was inhibited with okadaic acid (Cell Signaling Technology) and p38 MAPK was inhibited with PD169316 (Cayman Chemical). Pharmacological reagents were prepared in DMSO as a 10 mM stock and diluted 1/200 in fish water for immersion or PBS for intravitreal injections. Control fish were treated with vehicle.

Immunofluorescence and *in situ* hybridization {#s4-7}
----------------------------------------------

Zebrafish samples were prepared for immunofluorescence as previously described ([@bib17]; [@bib46]; [@bib46]). Primary antibodies used in this study: anti-pSmad3, Abcam Cat. \# ab52903 (1/200); Zpr-1 and Zn-5, Zebrafish International Resource Center (1/500 and 1/1000, respectively); anti-HuC/D, Abcam, Cat. \#ab210554 (1/500); anti-PKC~β1~, Santa Cruz Biotechnology, Cat. \#SC-8049 (1/200); anti-glutamine synthetase (GS), Sigma-Aldrich, Cat. \#MAB302 (1/500); anti-SOX9, EMD Millipore, Cat. \#AB5535 (1/500); anti-BrdU, Thermo Fisher, Cat. \# MA 1--82088 (1/500) and Cat. \# B35128 (1/500, clone MoBu-1 for co-staining with EdU Click-It chemistry). Secondary antibodies: Alexa Flour 555 Donkey anti Mouse-IgG (H+L), Thermo Fisher Cat. \# A31570 (1:500); Alexa flour 555 Donkey anti Rabbit IgG (H+L), Thermo Fisher, Cat \# A31572 (1:500); Alexa flour 555 Donkey anti Sheep IgG (H+L) Thermo Fisher Cat \#A21436. Cy3, Jakson Immuno research labs, Cat \#712-166-150 (1:500); Alexa Flour 488 donkey anti mouse Thermo Fisher Cat. \# A21202 (1:500); Alexa Flour 488 goat anti rabbit Thermo Fisher Cat. \# A11008 (1:500); Cy5 goat anti mouse, Thermo Fisher Cat. \# A10524 (1:500); and Alexa Flour 647 goat anti rabbit Thermo Fisher Cat \# A21244 (1:500). *In situ* hybridization was performed as described previously ([@bib2]).

Microscopy, TUNEL, cell quantification, and statistical analysis {#s4-8}
----------------------------------------------------------------

BrdU and EdU labelling were used to identify and quantify proliferating cells in retinal sections as previously described ([@bib17]; [@bib46]; [@bib69]; [@bib66]; [@bib67]). TUNEL assays were performed on retinal sections using the *in situ* cell death, fluorescein kit (Sigma Aldrich, Cat \# 11684795910). Images were captured by a Zeiss Axiophot fluorescence microscope or a Leica DM2500 microscope. Autofluorescence is defined as variable, background fluorescence that can be detected in multiple channels. All experiments were done in triplicate (three trials) with three animals per trial unless otherwise indicated. We routinely quantify the total number of proliferating cells around the injury site in all nuclear layers and also the number of proliferating cells restricted to the INL in order to be sure proliferative changes represent MG proliferation and are not solely due to rod progenitor proliferation. Unless specifically stated, quantification shown in graphs is proliferation in all nuclear layers at the injury site. Quantification of pSmad3 immunofluorescence was restricted to the area surrounding the injury site and represents the field of view. Error bars are standard deviation (SD). ANOVA with Fisher\'s PLSD *post hoc* analysis was used for multiple parameter comparison; two-tailed Student\'s *t* test was used for single parameter comparison.
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**Acceptance summary:**

This study nicelydemonstrates that Tgfb3 controls Müller glia quiescence in zebrafish via non-canonical Tgfb signaling. Data also suggest that Notch signaling, and possibly PP2A, act downstream of Tgfb3 which provides additional mechanistic insight into the regenerative process. There is substantial interest in how/why zebrafish possess the capacity to regenerate retinal neurons from Müller glia after injury in comparison to mammals, which cannot. Interestingly, analyses of mouse retinae suggest that Tgfb3 expression is not detectable in mouse Müller glia, which might contribute to their inability to stimulate a regenerative response after retinal injury.

**Decision letter after peer review:**

Thank you for submitting your article \"Tgfb3 inhibits retina regeneration via a PP2A-Notch signaling pathway\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Jeffrey Gross as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by Kathryn Cheah as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The paper by Goldman and colleague investigates how Tgfb-signaling influences the formation of Müller glia-derived progenitor cells in the fish retina. The authors utilize a variety of experimental manipulations that include state of the art genetic tools, including a constitutively active Alk5, heat-shock-induced Tgfb3, RBP-j/Notch reporter line, and generate a CRISPR-Cas9 deleted *tgfb3^-/-^* fish. Collectively, their data support a model in which resting Müller glia express elevated levels of Tgfb3 and that forced expression of Tgfb3 suppresses the proliferation of progenitors. Furthermore, their data suggest that the Tgfb3-signaling that suppresses proliferation is mediated, in part, through PPP2CA, and possibly also by promoting Notch-signaling.Overall, this is a generally well done study and one that will be of broad interest to the field.

Essential revisions:

1\) The link between Tgfb3/pSmad3, PP2A signaling, and the Notch pathway is potentially the most novel aspect of the paper but is not fully developed or characterized. The authors state that Tgfb3-PP2A signaling \"impinges\" on Notch signaling, but the lack of mechanistic insight into the relationship between these pathways and retina regeneration is disappointing and needs to be experimentally clarified.

2\) The findings regarding *ppp2ca* are interesting. However, it seems likely (and is suggested by existing scRNA-seq databases) that *ppp2ca* and all associated catalytic, structural and regulatory subunits are widely expressed in retinal neurons and glia. Thus, intravitreal delivery of okadaic acid is likely to broadly inhibit *ppp2c* in many different retinal cells (and perhaps also have off-target effects). Without targeted inhibition to MG or better descriptions of patterns of expression, the authors should use caution when asserting that *ppp2ca*-mediates non-canonical Tgfb3-signaling to suppress the formation of progenitor cells in damaged fish retinas. Interpretations and conclusions regarding *ppp2ca* should be softened, unless addition targeted experiments are performed that better support this pathway.

3\) The findings of current paper have not been adequately discussed in the context of another recent paper from the Ramachandran lab. (Sharma et al., 2020) or Raymond lab (Lenkowski et al., 2013). Many of the findings from the current study are entirely contradictory, despite investigation of similar pathways and use of similar reagents. Particular with respect to patterns of expression of Tgfb isoforms and increases in proliferation of progenitors with the addition of Tgfb1 (Sharma et al., 2020). Additional discussion and explicit comparison of results here is needed.

4\) The authors report effective suppression of pSmad3 in resting MG by systemic exposure to Alk5 inhibitors. SB431542 was also used in the study from Sharma and colleagues. It is not clear why the current study did not apply intravitreal SB431542 (similar to okadiac acid or p38 inhibitor) to test whether proliferating of progenitors is influenced by inhibition of Alk5 and, presumptively, failure to up-regulate pSmad3.

5\) Normally Tgfbs are secreted as latent factors and require activation by gelatinases. Is it assumed that the *hsp*-driven Tgfb3 is produced as a latent form and then instantly activated by extracellular gelatinases?

6\) Only once (for treatment with okadaic acid) are dying cells assessed. Since levels of damage are linked to numbers of proliferating progenitors, it seems prudent to assess levels of cell death with different manipulations to determine whether treatments impact neuronal damage, which in turn might impact numbers of proliferating cells. For example, is there more or less cell death in damaged retinas with loss of tgfb3 or ca-Alk5?

7\) For Figure 1D, how were the BrdU cells quantified? It looks like the number of BrdU cells in the INL is similar or even increased, but the number of BrdU cells in the ONL are decreased. Are the cells in the ONL derived from MG? Please clarify.

8\) It is surprising that gene expression changes are detectable among Tgfb ligands when using whole retina RNA and the needle poke model. Why was whole retina RNA used in Figure 2? Related, why are Tgfb levels sometimes normalized to Tgfb1 and sometimes to GAPDH?

9\) Figure 1---figure supplement 1 -- the labeling for pSmad3 in DMSO-treated retinas is strong. However, in inhibitor-treated retinas not only is the nuclear pSmad3 missing from the nuclei of Müller glia, but all of the background labeling is gone, as is autofluorescence in photoreceptor outer segments. This suggests the images were taken at different exposures or post-hoc processing was different. More generally, by what criterion is the fluorescence detected in some of the images referred to as autofluorescence?

10\) From a scholarly perspective, the authors are undoubtedly aware that there are many labs doing retina regeneration, yet far too many of the citations only cite work from the Goldman lab. As one simple example, numerous papers have demonstrated a role for Ascl1 (MASH-1) in retina regeneration. A full scholarly account should cite the full breadth of papers across both the fish and mouse models, especially since those findings work together to validate a key role for Ascl1.

11\) A few of the analyses lack quantification and statistical analyses (e.g. Figure 1B, C; Figure 7A).

12\) All bar graphs should be remade to show individual data points.

10.7554/eLife.55137.sa2

Author response

> Essential revisions:
>
> 1\) The link between Tgfb3/pSmad3, PP2A signaling, and the Notch pathway is potentially the most novel aspect of the paper but is not fully developed or characterized. The authors state that Tgfb3-PP2A signaling \"impinges\" on Notch signaling, but the lack of mechanistic insight into the relationship between these pathways and retina regeneration is disappointing and needs to be experimentally clarified.

We have provided additional data (Figure 7E) showing Tgfb3 stimulated hey1 expression which is a Notch-reporter gene in the zebrafish retina (Cell Reports 19: 849-62, 2017). Our data also suggest Tgfb3 may be regulating Notch signaling through its actions on *dll4*. These data, along with the stimulatory effect Tgfb3 has on Notch reporter fish that harbor multiple RBP-Jk binding sites (*tp1:mCherry*) strongly supports the idea that Tgfb3 acts, at least partly, through Notch signaling to regulate MG quiescence. The Results and Discussion section were revised to include our new data and clearly state that additional studies are needed to reveal PP2A mechanism of action (see end of Results and Discussion sections). We also edited the title of the paper for clarity.

We feel that requesting additional experiments to reveal mechanistic details of how Tgfb3 and PP2A mediate their effects on Müller glia proliferation would unreasonably delay publication beyond a year. For example, mechanistic insight into PP2A's action will require the generation of new transgenic fish that allow for pulldown of Alk5 and PP2A so we can investigate if there is a direct interaction (there are no antibodies that work in fish for this analysis). Production of new transgenic lines and their analysis would take over a year to complete. Because PP2A data is a minor component of the paper (only Figure 6) and because it would take a large amount of time to further investigate its mechanism of action, we prefer to relegate additional mechanistic analysis to a future study.

> 2\) The findings regarding ppp2ca are interesting. However, it seems likely (and is suggested by existing scRNA-seq databases) that ppp2ca and all associated catalytic, structural and regulatory subunits are widely expressed in retinal neurons and glia. Thus, intravitreal delivery of okadaic acid is likely to broadly inhibit ppp2c in many different retinal cells (and perhaps also have off-target effects). Without targeted inhibition to MG or better descriptions of patterns of expression, the authors should use caution when asserting that ppp2ca-mediates non-canonical Tgfb3-signaling to suppress the formation of progenitor cells in damaged fish retinas. Interpretations and conclusions regarding ppp2ca should be softened, unless addition targeted experiments are performed that better support this pathway.

We have softened our statements throughout the paper, including title and Abstract.

> 3\) The findings of current paper have not been adequately discussed in the context of another recent paper from the Ramachandran lab. (Sharma et al., 2020) or Raymond lab (Lenkowski et al., 2013). Many of the findings from the current study are entirely contradictory, despite investigation of similar pathways and use of similar reagents. Particular with respect to patterns of expression of Tgfb isoforms and increases in proliferation of progenitors with the addition of Tgfb1 (Sharma et al., 2020). Additional discussion and explicit comparison of results here is needed.

We address this in the Discussion and also added a little more context on this subject to the Introduction. It is important to realize that even among the published papers and between multiple papers coming from the same group -- inconsistencies emerge; we have included this information in the Discussion.

> 4\) The authors report effective suppression of pSmad3 in resting MG by systemic exposure to Alk5 inhibitors. SB431542 was also used in the study from Sharma and colleagues. It is not clear why the current study did not apply intravitreal SB431542 (similar to okadiac acid or p38 inhibitor) to test whether proliferating of progenitors is influenced by inhibition of Alk5 and, presumptively, failure to up-regulate pSmad3.

This experiment was added to Figure 6. Consistent with Alk5 kinase activity being necessary for Tgfb3 effects on MG proliferation, we find SB431542 rescues MG proliferation in the Tgfb3 treated retina. Text was added to Results to describe this result.

> 5\) Normally Tgfbs are secreted as latent factors and require activation by gelatinases. Is it assumed that the hsp-driven Tgfb3 is produced as a latent form and then instantly activated by extracellular gelatinases?

We added to the second paragraph of the Discussion the mechanism underlying Tgfb activation. Prodomain cleavage takes place in golgi prior to secretion and the non-covalent complex of latency domain and mature peptide bind integrin in the extracellular matrix which stimulates release of the mature protein so it can interact with its receptor. These proteins don't require extracellular gelatinases for their activity.

> 6\) Only once (for treatment with okadaic acid) are dying cells assessed. Since levels of damage are linked to numbers of proliferating progenitors, it seems prudent to assess levels of cell death with different manipulations to determine whether treatments impact neuronal damage, which in turn might impact numbers of proliferating cells. For example, is there more or less cell death in damaged retinas with loss of tgfb3 or ca-Alk5?

We include the TUNEL data for ca-Alk5 overexpression and Tgfb3 loss in Figure 1---figure supplement 1B and Figure 4---figure supplement 1C, respectively. We found ca-Alk5 suppressed TUNEL+ cell number in the injured retina, while Tgfb3 loss had no effect. We comment on the ca-Alk5 effect on TUNEL+ cells at the end of the first section of the Results under the heading "pSmad3 signaling is suppressed..." Our original data, presented in Figure 6---figure supplement 1B, showed Tgfb3 overexpression and okadaic acid treatment had no effect on TUNEL+ cells in the injured retina.

> 7\) For Figure 1D, how were the BrdU cells quantified? It looks like the number of BrdU cells in the INL is similar or even increased, but the number of BrdU cells in the ONL are decreased. Are the cells in the ONL derived from MG? Please clarify.

Although MG nuclei migrate towards the ONL and divide at the base of the ONL, MG-derived progenitors divide in the INL. Thus, counting all proliferating cells is appropriate. Because we use a needle poke injury, proliferating cells at the site of injury are often displaced towards the GCL, while proliferating cells flanking the injury site are not displaced. This is what is observed in this picture. The reviewer is only looking at the displaced cells in the top Wt panel not the cells restricted to the INL. To help clarify this we labelled the various layers in the top panel. We added a couple of sentences to the Materials and methods subsection "Microscopy, cell quantification and statistical analysis", to clarify how we do our counts and what is reported.

> 8\) It is surprising that gene expression changes are detectable among Tgfb ligands when using whole retina RNA and the needle poke model. Why was whole retina RNA used in Figure 2? Related, why are Tgfb levels sometimes normalized to Tgfb1 and sometimes to GAPDH?

Figure 2A and B use RNA from FACS purified GFP+ MG from gfap:GFP and 1016 tuba1a:GFP fish and we added this to the figure legend (it is also in the Materials and methods section). We used total RNA from retinas for the time course experiments since it would be too costly and complex to FACS purify MG for every time point. However, the reason we can detect gene expression changes is that we give the fish 8-10 needle pokes when we analyze total retinal RNA by qPCR, which activates a regenerative response in most MG. This information was added to the Materials and methods subsection -- "Animals, injury models, and cell proliferation assays". All samples are corrected for variations in RNA amount using gapdh as a normalizer; however, to illustrate the magnitude of *tgfb3* RNA abundance relative to the other injury-regulated *tgfb* genes, we normalized to *tgfb1b* which is the least abundant *tgfb* ligand encoding gene in MG.

> 9\) Figure 1---figure supplement 1 -- the labeling for pSmad3 in DMSO-treated retinas is strong. However, in inhibitor-treated retinas not only is the nuclear pSmad3 missing from the nuclei of Müller glia, but all of the background labeling is gone, as is autofluorescence in photoreceptor outer segments. This suggests the images were taken at different exposures or post-hoc processing was different. More generally, by what criterion is the fluorescence detected in some of the images referred to as autofluorescence?

We reimaged the sections and provide a new figure. Autofluorescence is defined as variable, background fluorescence that can be detected in multiple channels. This statement was added to the Materials and methods section.

> 10\) From a scholarly perspective, the authors are undoubtedly aware that there are many labs doing retina regeneration, yet far too many of the citations only cite work from the Goldman lab. As one simple example, numerous papers have demonstrated a role for Ascl1 (MASH-1) in retina regeneration. A full scholarly account should cite the full breadth of papers across both the fish and mouse models, especially since those findings work together to validate a key role for Ascl1.

We added references as suggested.

> 11\) A few of the analyses lack quantification and statistical analyses (e.g. Figure 1B, C; Figure 7A).

Quantification has been added to these figures.

> 12\) All bar graphs should be remade to show individual data points.

Graphs were remade as requested with individual data points shown.

[^1]: These authors contributed equally to this work.
